Concepedia

Richard D. Hartman

RD

Statistics

Publications

38

Citations

2.2K

H-Index

25

Active since

1978

Affiliations

University of Maryland, Baltimore(Current)

Penn State Milton S. Hershey Medical Center

Novartis (United States)

Novartis (Switzerland)

Pennsylvania State University

Richard D. Hartman is an author at University of Maryland, Baltimore specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Publications per year

1978–2023

38

Publications

38

A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease

Martin R. Farlow, Ravi Anand, John Messina et al. · European Neurology · 2000 · 328 citations

, , +17

An efficacy and safety analysis of Exelon<sup>®</sup> in Alzheimer’s disease patients with concurrent vascular risk factors

Vinod Kumar, R. Anand, John Messina et al. · European Journal of Neurology · 2000 · 162 citations

, , +17

Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease

Steven G. Potkin, Ravi Anand, Kirsten Fleming et al. · The International Journal of Neuropsychopharmacology · 2001 · 160 citations · Full text

, , +17

Long-term effects of rivastigmine in moderately severe Alzheimer's disease

P. Murali Doraiswamy, Kousik Krishnan, Ravi Anand et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 109 citations

, , +14

A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease

Fiona Crawford, Melissa Freeman, John A. Schinka et al. · Neurology · 2000 · 108 citations

, , +15

1–5 of 38